Fig. 1. Sunburst diagram of the reclassification of patients with AML from the WHO 2017 classification to the WHO 2022 classification and the ICC.
Abbreviations: ICC, International Consensus Classification; AML-NOS, AML not otherwise specified; AML with biCEBPA, AML with biallelic mutations of CEBPA; -r, rearrangement; AML with RUNX1, AML with mutated RUNX1; MR, myelodysplasia-related; AML-MRC, AML with MR changes; AML-DBD, AML defined by differentiation; AML with CEBPA, AML with CEPBA mutation; AML-MR-G, AML with MR gene mutations; AML-MR-CG, AML with MR cytogenetic abnormalities; MDS, myelodysplastic syndrome; MDS/MPN, myelodysplastic/myeloproliferative neoplasm.

Ann Lab Med 2025;45:170~177 https://doi.org/10.3343/alm.2024.0194